|
|
|
WeeklyReport: Global weakness affects Domestic bourses: Mkts down 1% for the Week
|
|
Saturday, February 6, 2016 |
| | | Market Commentary | | | Global weakness affects Domestic bourses: Mkts down 1% for the Week | | The Indian markets registered losses this Week led by global distress. The Sensex and Nifty fell 1.02%-0.98% each for the week ended February 05, 2016. | |
 Major Headlines for the week:
Indian indices:
Welcome to the 'Weekly Market Wrap' for Friday, February 05, 2016 where key indices edged lower as weakness in global stocks affected sentiment on the domestic bourses. Nevertheless, the market recouped some losses in last two sessions of the week, tracking recovery in global stocks triggered by reduced expectations for further interest rate increases from the US Federal Reserve in this calendar year.
Key indices fell in three out of five sessions in the week ended Friday, 5 February 2016. Meanwhile, the Reserve Bank of India kept its benchmark interest rate viz. the repo rate unchanged at 6.75% after a scheduled monetary policy review on 2 February 2016.
The BSE Mid-Cap index shed 0.78%. The decline for this index was lower in percentage terms than the Sensex's decline. The BSE Small-Cap index lost 2.76%. The decline for this index was higher in percentage terms than the Sensex's decline.
From the 30-share Sensex pack, 15 stocks fell and the rest rose in the week ended Friday, 5 February 2016.
The barometer index S&P BSE Sensex, declined 253.72 points or 1.02% to settle at 24,616.97. The 50-unit Nifty 50 index dropped 74.45 points or 0.98% at 7,489.10. Weekly market trend from February 01 - February 05, 2016
Feb 01- Trading for the week started on a weak note. After swinging between positive and negative zone alternately in intraday trade, the key benchmark indices registered small losses on Monday. The Sensex fell 45.86 points or 0.18% to settle at 24,824.83, its lowest closing level since 28 January 2016.
Feb 02- Stocks of metal and mining companies, oil sector firms and public sector companies led losses for key benchmark indices on Tuesday. The Sensex lost 285.83 points or 1.15% to settle at 24,539, its lowest closing level since 28 January 2016.
Feb 03- Metal, power and oil sector stocks led losses as key benchmark indices edged lower for the third day in a row on Wednesday. The Sensex lost 315.68 points or 1.29% to settle at 24,247.21, its lowest closing level since 21 January 2016.
Feb 04- Stocks of metal and mining firms, oil exploration and production companies and index heavyweight Infosys led gains for key benchmark indices on Thursday, 4 February 2016, in what was a choppy trading session on Thursday. The Sensex rose 115.11 points or 0.48% to settle at 24,338.43, its highest closing level since 2 February 2016.
 Feb 05- Trading for the week ended on a positive note, as key equity benchmark indices registered strong gains on Friday, on firmness in global stocks. The Sensex rose 278.54 points or 1.14% to settle at 24,616.97. Global indices:
Most of the global markets ended in the red zone except Shanghai Composite which rose 0.94% while Nasdaq fell 5.44%, DAX100 fell 5.22% and CAC40 dropped 4.90%.
 Sectoral and stock screening:
Among the 13 sectors the top gainers were S&P BSE FMCG rose 1.42%, S&P BSE CD rose 0.49% and S&P BSE TECk rose 0.42%. The only losers were: S&P BSE Power down 5.70%, S&P BSE Oil&Gas down 3.89% and S&P BSE Realty fell 3.40%
| | Looking at the 'A' group stocks, the top three gainers of the week were: ABB up 16.21%, Vakrangee rose 13.79% and Bajaj Finance up 13.50%
Top three losers of the week were: Crompton Greaves down 25.83%, Wockhardt fell 17.81% and Arvind was down 12.69%
FII/MF activity:
The foreign institutional investors (FIIs) have been the net sellers of the Indian stocks to the tune of Rs156.20 crore as on February 04, 2016 and the domestic investors sold Indian shares worth a net of Rs786.50 crore as on February 02, 2016. | | TOP MOVERS (GROUP A) |  | | | | | | | | | | | | Bajaj Finance | 6,705.80 | 13.50 | | | | | Crompton Greaves | 126.90 | 25.83 | | | | | | | | | | | FII/MF ACTIVITIES | | | | | | | Gross purchase | 14,685.56 | 1,478.10 | | | Gross sale | 14,841.76 | 2,264.60 | | | Net investment | -156.20 | -786.50 | | | | | | | | *As on February 04 , 2016
**As on February 02 , 2016 | | | | Market Outlook for the coming week!
In the coming week, macroeconomic data, Q3 results of India Inc., trend in global markets, investment by foreign portfolio investors (FPIs) and domestic institutional investors (DIIs), the movement of rupee against the dollar and crude oil price movement will dictate trend on the bourses in the near term.
On macro front, the government will announce data on gross domestic product (GDP) for Q3 December 2015 on Monday, 8 February 2016.
Data on industrial production for December 2015 will be announced by the government after market hours on Friday, 12 February 2016.
The government will also announce after market hours on Friday, 12 February 2016, data on inflation based on the consumer price index (CPI) for January 2016.
The results season of India Inc. is drawing to a close by next week.
On global front, Chinese stock markets remain closed next week for the Lunar New Year holiday.
In the US, Federal Reserve Chairwoman Janet Yellen presents semi-annual monetary report to House Financial Services Committee, in Washington on Wednesday, 10 February 2016 and to Senate Banking Committee on Thursday, 11 February 2016. | | | | To know more about our products and services, click here. |  | REGISTRATION DETAILS Regd Add: Sharekhan Limited, 10th Floor, Beta Building, Lodha iThink Techno Campus, Off. JVLR, Opp. Kanjurmarg Railway Station, Kanjurmarg (East), Mumbai - 400042, Maharashtra. Tel: 022 - 61150000. Sharekhan Ltd.: SEBI Regn. Nos. BSE - INB/INF011073351 ; BSE- CD ; NSE - INB/INF231073330 ; CD-INE231073330 ; MCX Stock Exchange - INB/INF261073333 ; CD-INE261073330 ; DP - NSDL-IN-DP-NSDL-233-2003 ; CDSL-IN-DP-CDSL-271-2004 ; PMS-INP000000662 ; Mutual Fund-ARN 20669 ; Commodity trading through Sharekhan Commodities Pvt. Ltd.: MCX-10080 ; (MCX/TCM/CORP/0425) ; NCDEX-00132 ; (NCDEX/TCM/CORP/0142) ; NCDEX SPOT-NCDEXSPOT/116/CO/11/20626 ; For any complaints email at igc@sharekhan.com ; Disclaimer: Client should read the Risk Disclosure Document issued by SEBI & relevant exchanges and Do's & Don'ts by MCX & NCDEX and the T & C on www.sharekhan.com before investing. | | | | "This document has been prepared by Sharekhan Ltd. (SHAREKHAN) and is intended for use only by the person or entity to which it is addressed to. This document may contain confidential and/or privileged material and is not for any type of circulation and any review, retransmission, or any other use is strictly prohibited. This document is subject to changes without prior notice. This document does not constitute an offer to sell or solicitation for the purchase or sale of any financial instrument or as an official confirmation of any transaction. Though disseminated to all customers who are due to receive the same, not all customers may receive this report at the same time. SHAREKHAN will not treat recipients as customers by virtue of their receiving this report.
The information contained herein is obtained from publicly available data or other sources believed to be reliable and SHAREKHAN has not independently verified the accuracy and completeness of the said data and hence it should not be relied upon as such. While we would endeavour to update the information herein on a reasonable basis, SHAREKHAN, its subsidiaries and associated companies, their directors and employees ("SHAREKHAN and affiliates") are under no obligation to update or keep the information current. Also, there may be regulatory, compliance, or other reasons that may prevent SHAREKHAN and affiliates from doing so. This document is prepared for assistance only and is not intended to be and must not alone be taken as the basis for an investment decision. Recipients of this report should also be aware that past performance is not necessarily a guide to future performance and value of investments can go down as well. The user assumes the entire risk of any use made of this information. Each recipient of this document should make such investigations as he deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document (including the merits and risks involved), and should consult his own advisors to determine the merits and risks of such an investment. The investment discussed or views expressed may not be suitable for all investors. We do not undertake to advise you as to any change of our views. Affiliates of SHAREKHAN may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report.
This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject SHAREKHAN and affiliates to any registration or licencing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. Persons in whose possession this document may come are required to inform themselves of and to observe such restriction. Either SHAREKHAN or its affiliates or its directors or employees/representatives/clients or their relatives may have position(s), make market, act as principal or engage in transactions of purchase or sell of securities, from time to time or may be materially interested in any of the securities or related securities referred to in this report and they may have used the information set forth herein before publication. SHAREKHAN may from time to time solicit from, or perform investment banking, or other services for, any company mentioned herein. Without limiting any of the foregoing, in no event shall SHAREKHAN, any of its affiliates or any third party involved in, or related to, computing or compiling the information have any liability for any damages of any kind. The analyst certifies that all of the views expressed in this document accurately reflect his or her personal views about the subject company or companies and its or their securities and do not necessarily reflect those of SHAREKHAN. Further, no part of the analyst's compensation was, is or will be, directly or indirectly related to specific recommendations or views expressed in this document." Compliance Officer: Ms. Namita Amod Godbole; Tel: 022-6115000; e-mail: compliance@sharekhan.com
Contact: myaccount@sharekhan.com | | | |
|
posted by Anonymous @ 2:04 AM  |
|
|
|
|
|
